Sildenafil Tablet, Film Coated
Product Images NDC 52817-342

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 52817-342). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Trupharma Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure Image (08a86eb2 9e83 4efb Aa63 117b9cbf7221 01)

Chemical structure of sildenafil, showing its molecular arrangement with labeled atoms and bonds representative of the active ingredient in the product SILDENAFIL tablets by TruPharma LLC.*

FDA Label Image

Image 1 (08a86eb2 9e83 4efb Aa63 117b9cbf7221 02)

A line graph showing systolic blood pressure changes (in mm Hg) over 24 hours post-dose comparing Sildenafil 100 mg to placebo. The x-axis represents time in hours post-dose, and the y-axis represents systolic blood pressure changes. Two curves depict the data for Sildenafil and placebo groups across the time points from pre-dose to 24 hours post-dose.*

FDA Label Image

Image3 (08a86eb2 9e83 4efb Aa63 117b9cbf7221 03)

A line graph showing change in systolic blood pressure (SBP) over time (hours post dose) comparing two treatments: Doxazosin plus Placebo and Doxazosin plus Sildenafil 25 mg. The graph plots measurements from 0 to 8 hours, with data points indicating the SBP change in mmHg on the vertical axis.*

FDA Label Image

Image4 (08a86eb2 9e83 4efb Aa63 117b9cbf7221 04)

A line graph comparing changes in systolic blood pressure (SBP) over time post-dose (hours) between two treatments: Doxazosin with Placebo and Doxazosin with Sildenafil 50 mg. The x-axis represents time post-dose in hours, and the y-axis shows change in SBP in mmHg. Data points indicate blood pressure fluctuations for each treatment group.*

FDA Label Image

Image (08a86eb2 9e83 4efb Aa63 117b9cbf7221 05)

A line graph comparing the effects over 8 hours after dosing of two treatments: Doxazosin combined with Sildenafil 100 mg versus Doxazosin combined with placebo. The y-axis measures pressure in mmHg, and the x-axis represents time in hours after dosing. The graph shows changes in values for both treatments over the 8-hour period.*

FDA Label Image

Image (08a86eb2 9e83 4efb Aa63 117b9cbf7221 06)

A line graph comparing plasma concentration (ng/mL) over 24 hours post dose between a commercial sildenafil tablet and a test treatment, showing concentration on the y-axis and time on the x-axis with points representing measured values for each formulation.*

FDA Label Image

Image (08a86eb2 9e83 4efb Aa63 117b9cbf7221 07)

A bar graph titled 'Effect of Sildenafil on Maintenance of Erection by Baseline Score' showing the percentage of patients at endpoint on the y-axis and baseline score on the x-axis. Multiple bars per baseline score represent different categories labeled 0 through 5, illustrating trends in patient responses across baseline scores.*

FDA Label Image

Image5 (08a86eb2 9e83 4efb Aa63 117b9cbf7221 08)

A bar graph titled 'Effect of Placebo on Maintenance of Erection by Baseline Score,' showing the percentage of patients at the endpoint on the vertical axis and baseline score on the horizontal axis ranging from 0 to 5. Multiple bars for scores 0 to 5 represent different categories labeled 0 through 5 in a legend, illustrating distribution of patients maintaining erection across baseline scores under placebo conditions.*

FDA Label Image

Image (08a86eb2 9e83 4efb Aa63 117b9cbf7221 09)

A bar chart comparing the percentage of patients reporting improvement across four treatment groups: Placebo, Sildenafil 25 mg, Sildenafil 50 mg, and Sildenafil 100 mg. The vertical axis represents the percentage of patients reporting improvement, ranging from 0% to 100%, with bars indicating 24% for Placebo, 63% for Sildenafil 25 mg, 74% for Sildenafil 50 mg, and 82% for Sildenafil 100 mg. The horizontal axis lists the treatment groups by name and sample size.*

FDA Label Image

Sildenafil Tablet-25mg (08a86eb2 9e83 4efb Aa63 117b9cbf7221 10)

Sildenafil Tablets USP 25 mg film-coated tablets prescription label by TruPharma LLC. The label states each tablet contains sildenafil citrate USP equivalent to 25 mg sildenafil. It includes storage instructions, usual dosage guidance to see accompanying info, and a barcode. The package contains 30 tablets and notes distribution by TruPharma LLC, Tampa, FL, with manufacturing by Rubicon Research Private Limited in India.*

FDA Label Image

Sildenafil Tablet-50mg (08a86eb2 9e83 4efb Aa63 117b9cbf7221 11)

SILDENAFIL 50 mg film-coated tablets packaging label from TruPharma LLC. The label states each tablet contains sildenafil citrate USP equivalent to 50 mg sildenafil. The package contains 30 tablets. Storage instructions and distributor, manufacturer details are included, along with a barcode and NDC number 52817-341-30. Manufactured by Rubicon Research Private Limited, India.*

FDA Label Image

Sildenafil Tablet-100mg (08a86eb2 9e83 4efb Aa63 117b9cbf7221 12)

Label for Sildenafil Tablets USP 100 mg, film-coated oral tablets in a container of 30 tablets. The label shows the active ingredient strength and formulation, distributed by TruPharma LLC and manufactured by Rubicon Research Private Limited in India. Includes storage instructions and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.